International
Asia Pacific
Trinity has been working in the APAC region for over 10 years and has completed over 550 projects related to the region. There are ~20 Trinity experts associated with the Asia Pacific Center of Excellence.
Trinity supports global and local clients with commercialization strategies in the APAC region, in addition to supporting local clients with global expansion strategies.
Blog
Early China Launch of PIASKY® in the Fight Against PNH
In February 2024, the National Medical Products Administration (NMPA), China’s drug regulator, granted priority review approval to Roche’s PIASKY (crovalimab), an injectable C5 inhibitor for the treatment of Paroxysmal Nocturnal Hemoglobinuria (PNH). PNH is a rare genetic blood disorder in which the patient’s immune system attacks and destroys red blood cells and platelets. As the […]
Read More
Blog
Japan Pricing Policy Reform 2024
Executive Summary The Central Social Insurance Medical Council, the key Japanese reimbursement policy panel known as Chuikyo, introduced the 2024 drug pricing reform in April 2024. Some key features of the reform plan include: The reform outlines a suite of measures aimed at driving innovation while also addressing drug lags (delay in manufacturers launching drugs in Japan […]
Read More
Webinars
2023 NRDL Update: An Ongoing Voyage of Innovation and Accessibility
Available On Demand
How can manufacturers strategize for pricing and market access success amidst the evolving landscape of China’s NRDL? As China continues to be a key pharmaceutical market, understanding the latest National Reimbursement Drug List (NRDL) trends and policy evolvement is crucial for manufacturers aiming to achieve successful access and pricing outcomes. In this webinar, a panel […]
Watch Now
If you have any questions, we’re here to answer them.
We look forward to helping identify solutions for you.